GMP · FSSAI · ISO-certified manufacturing
Tablets & CapsulesImmunity & Daily Nutrition

Veinova 360

1000 mg coated tablet

A vein and circulation-support tablet on sariva, manjistha and gotu kola with diosmin and horse chestnut, for people who stand or sit all day.

Minimum order
500 tablets per SKU
Lead time
14–20 working days after artwork and advance confirmation
Shelf life
24 months from manufacture
Veinova 360, Tablets & Capsules manufactured by NutraHerbal
Why this product

Where Veinova 360 sits in the market

Varicose veins, heavy legs and swollen ankles affect a lot of people who stand for a living, teachers, nurses, shop staff, security guards, and almost nothing on the Indian shelf addresses them. Veinova 360 combines the classical raktashodhak herbs with diosmin and horse chestnut, the two ingredients European venous products are built on. Small category, very little competition, and an occupational audience that is easy to target.

Key ingredients

What it is built on

Diosmin

Citrus-derived flavonoid

The ingredient European venous products are built on.

Horse chestnut

Aesculus hippocastanum

Aescin-standardised; the other established venous ingredient.

Gotu kola

Centella asiatica

Classical mandukaparni, traditionally used for circulation.

Sariva

Hemidesmus indicus

Classical blood-purifier herb.

Benefits for your brand

What this SKU does for the business

Written for a brand owner deciding what to manufacture, not as consumer marketing copy, and without health claims we cannot stand behind.

01

An occupational audience you can target precisely

This complaint clusters in specific jobs, teaching, nursing, retail, security, long-haul driving. That makes paid targeting unusually efficient compared with broad health categories where you are guessing.

02

Almost no Indian competition

Venous support is a well-established category in Europe and barely exists on the Indian shelf. For a brand looking for a genuinely uncontested niche rather than another liver tablet, this is one of the best options here.

03

Diosmin is the credible core

Diosmin is the active in widely used European venous products. Including it at a stated dose means your product can stand next to an import and be compared on substance rather than on price.

04

Pregnancy-related demand

Leg swelling and varicose veins are common in pregnancy, which adds a second distinct audience. It needs careful, practitioner-aware messaging, but it is real and currently unserved.

05

Pairs with a topical gel

A leg gel or cream alongside the tablet gives the immediate cooling relief this customer wants while the tablet works on circulation. The combination converts noticeably better than either alone.

06

Loyal once it works

Because so little else is available, customers who find relief here stay for a long time and tell colleagues with the same job. Word of mouth within occupational groups is strong.

Composition

Per unit

IngredientQuantity
Diosmin200 mg
Horse chestnut extract (20% aescin)150 mg
Gotu kola extract150 mg
Sariva extract125 mg
Manjistha extract125 mg
Guggul extract100 mg
Vitamin C & rutin40 mg / 50 mg
Excipients & coatingq.s. to 1000 mg

Composition is adjustable under our custom formulation route. Changes restart the stability and documentation clock, allow an extra three to four weeks.

Packaging

Available formats

↗60 tablets, HDPE jar
↗60 tablets, alu-alu blister in mono carton
↗90 tablets, value pack
↗Tablet + leg gel combo kit

Label design, carton artwork and shipper cartons are available as a service. See packaging development.

Market research

What the demand actually looks like

Our read of this category from manufacturing for it. Price bands and volumes are indicative planning ranges for your own costing, not audited market data, and not a quotation.

Demand & seasonality

A small but entirely under-served category with steady year-round demand and a modest summer lift when swelling is worse.

Search & language

Moderate volume, low competition. Hindi queries are descriptive ("pairo ki nason me dard", "varicose veins ka ilaj") and English queries are clinical. Ranking here is much easier than in the major categories.

Who buys it

Adults 35–60 in standing occupations, plus pregnant and postpartum women. Motivated by visible symptoms and daily discomfort rather than by long-term prevention.

Indicative price band

Indicative retail positioning for 60 tablets sits in the ₹600–₹1,200 band. Diosmin is the main cost driver. Treat as a planning range.

Competitive picture

Nearly empty on the Indian Ayurvedic shelf, with a few expensive imports at the top. A reasonably priced local product with real actives has a clear run.

Channels that work

↗D2C
↗Marketplaces
↗Pharmacy counters
↗Clinics
Questions we actually get

Before you place the order

Can we claim it cures varicose veins?

No. Varicose veins are a structural problem and often need clinical treatment. Circulation support and leg comfort are the honest positions, and the label should say that persistent or worsening symptoms need a doctor.

Is it safe during pregnancy?

Horse chestnut is not generally recommended in pregnancy, so the standard label carries a pregnancy caution. If you specifically want to serve that audience we should develop a separate formulation with a practitioner involved.

Is this category big enough to bother with?

On its own, it is small. As an addition to an existing range aimed at older or occupationally specific customers, it is worth it, low competition, loyal buyers, and almost no one to bid against on content.

Do you make the leg gel?

Yes, a cooling leg gel is available in our personal-care range and it pairs naturally with this tablet.

Your idea, made tangible

Get a costing for Veinova 360

Tell us your pack format, target price point and first-order volume. We will send a specification sheet, a per-unit cost and a realistic first-batch date.

NutraHerbal manufactures food supplements, Ayurvedic proprietary medicines and cosmetics for business customers. Product information on this site describes composition, format and commercial positioning for brand owners. It is not medical advice, does not claim to diagnose, treat, cure or prevent any disease, and is not a substitute for consulting a qualified practitioner. Final label claims are the brand owner's responsibility and must be approved for the destination market.

WA